Northwest Medical Specialties, PLLC And Osborn Cancer Care Join Together With A Common Goal To Provide The Highest Quality Cancer Care In The Region Coming together is a beginning; keeping together is progress; working together is success. -Henry Ford
News provided by
Share this article
Share this article
TACOMA, Wash., April 27, 2021 /PRNewswire/ We are pleased to announce the exciting news that Northwest Medical Specialties, PLLC (NWMS) and Osborn Cancer Care will join together as a single entity. This decision was based on the desire from both organizations to extend and preserve their mission of providing the highest quality cancer care by partnering with like-minded providers who are dedicated to serving cancer patients in their own communities.
Northwest Medical Specialties, PLLC And Osborn Cancer Care Join Together With A Common Goal To Provide The Highest Quality Cancer Care In The Region prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Allegheny Health Network Offers T-VEC Virus-Based Treatment for Advanced Melanoma
Share Article
Pittsburgh-based Allegheny Health Network is offering patients with advanced melanoma treatment with an oncolytic (cancer-killing) virus called Imlygic or T-VEC. It is injected directly into the tumor, where it works by replicating inside the cancer cells.
AHN surgical oncologist Howard Edington, MD, talks with patient Paul Kirsch prior to treatment with T-VEC
“Unlike other therapies for advanced melanoma, T-VEC is usually well tolerated and is suitable for many patients, including the elderly. It also has a “bystander effect,” killing nearby tiny lesions in addition to the primary tumor.” - Howard Edington, MD, AHN surgical oncologist
ProMedica Cancer Institute praised for quality of care
A local cancer care center is being lauded as a result of its reaccreditation process.
The quality of care and the team working at ProMedica Cancer Institute received praise from the National Accreditation Program for Breast Centers.
“ProMedica patients are very fortunate to receive top-notch care from a really dedicated group of professionals,” said Hannah Gilmore of NAPBC.
A member of the accreditation agency s board of directors, Gilmore also is a site reviewer during the review process.
The accreditation covers the entire institute’s system, which includes the ProMedica Monroe Cancer Center at 800 Stewart Rd., according to ProMedica officials.
AHN Cancer Institute Opens Genomics Facility Offering Patients Next-Generation Gene Sequencing to Guide Treatment Decisions
Share Article
Pittsburgh-based Allegheny Health Network (AHN) Cancer Institute has opened a new Clinical Genomics Laboratory, offering comprehensive, advanced, in-house genomic testing that guides doctors in selecting treatments to give cancer patients their best chance at a good outcome.
William LaFramboise, PhD, Chief Genomics Technology Officer, Allegheny Health Network, and David Bartlett, MD, Chair, AHN Cancer Institute, in AHN s new Clinical Genomics Laboratory We believe that offering on-site genomic testing offers a number of advantages to our patients, including a quicker turnaround time and better stewardship of our patients’ samples. - David L. Bartlett, MD, Chair, AHN Cancer Institute